ÀڱðæºÎ¾Ï ¼±º°°Ë»ç·Î¼­ ÀÎÀ¯µÎÁ¾¹ÙÀÌ·¯½º DNA °Ë»çÀÇ ÀÓ»óÀû À¯¿ë¼º
Clinical efficiency of HPV DNA test as a screening test of cervical cancer

°è¸íÀÇ´ëÇмúÁö 2009³â 28±Ç 2È£ p.279 ~ p.285

±èÁöÇý(Kim Ji-Hae) - °è¸í´ëÇб³ ÀÇ°ú´ëÇÐ Áø´Ü°Ë»çÀÇÇб³½Ç
·ù³²Èñ(Ryoo Nam-Hee) - °è¸í´ëÇб³ ÀÇ°ú´ëÇÐ Áø´Ü°Ë»çÀÇÇб³½Ç
ÇÏÁ¤¼÷(Ha Jung-Sook) - °è¸í´ëÇб³ ÀÇ°ú´ëÇÐ Áø´Ü°Ë»çÀÇÇб³½Ç
Àüµ¿¼®(Jeon Dong-Suk) - °è¸í´ëÇб³ ÀÇ°ú´ëÇÐ Áø´Ü°Ë»çÀÇÇб³½Ç
±èÀç·æ(Kim Jae-Ryong) - °è¸í´ëÇб³ ÀÇ°ú´ëÇÐ Áø´Ü°Ë»çÀÇÇб³½Ç
Á¶Ä¡Èì(Cho Chi-Heum) - °è¸í´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç

Abstract

In spite of the enforcement of the screening program by cervical cytology (Pap smear), false negativity of conventional cytology is problematic and the sensitivity of cytology is highly variable. Therefore, newly developed tests based on molecular method to detect Human Paillomavirus (HPV) DNA have been introduced. Authors evaluated the sensitivity and specificity with efficacy of HPV DNA test as a screening test for cervical cancer according to the biopsy which is a gold standard method. Thirty-three of 52 (63.4%) patients who showed higher grade of severity than CIN II in biopsy were all positive (100%) in HPV DNA test, but Pap smear showed negative in one patient. Among 62 patients with positive HPV DNA but without results of cervical biopsy, 7 patients later revealed advancement of cytological findings during the first year
of follow-up. Since HPV DNA test showed higher sensitivity and negative predictive value for the detection of high-grade cervical lesions than cytology, it would be clinically efficiently used as a primary screening test for cervical cancer. In addition, more effective guidelines for combined usage with cytology would need to be established and further studies would also be required.

Å°¿öµå

cervical cancer, HPV, hybrid capture, Pap smear
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
Thirty-three of 52 (63.4%) patients who showed higher grade of severity than CIN II in biopsy were all positive (100%) in HPV DNA test, but Pap smear showed negative in one patient; Since HPV DNA test showed higher sensitivity and negative predictive value for the detection of high-grade cervical lesions than cytology, it would be clinically efficiently used as a primary screening test for cervical cancer.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå